A Double-blind, Crossover Comparison of Methylphenidate and Placebo in Adults with Childhood-Onset Attention-Deficit Hyperactivity Disorder

Archives of General Psychiatry

Volumn 52, Issue 6, 1995, Pages 434-443

  Spencer, Thomas ^a   Wilens, Timothy ^a   Biederman, Joseph ^a   Faraone, Stephen V ^a   Ablon, J Stuart ^b   Lapey, Kathleen ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADULT; ANXIETY; APPETITE DISORDER; ARTICLE; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; EUPHORIA; FEMALE; HUMAN; INSOMNIA; MALE; MINIMAL BRAIN DYSFUNCTION; ONSET AGE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SOCIOECONOMICS;

ADOLESCENT; ADULT; AGE FACTORS; AMBULATORY CARE; ANXIETY DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMORBIDITY; CROSS-OVER STUDIES; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FAMILY; FEMALE; HUMANS; MALE; MENTAL DISORDERS; METHYLPHENIDATE; MIDDLE AGED; PLACEBOS; TREATMENT OUTCOME;

EID: 0029062077     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1995.03950180020004     Document Type: Article

References (57)

1. Mannuzza S, Klein RG, Bonagura N, Malloy P, Giampino TL, Addalli KA. Hyperactive boys almost grown up, V: replication of psychiatric status. Arch Gen Psychiatry. 1991;48: 77–83.
2. Gittelman R, Mannuzza S, Shenker R, Bonagura N. Hyperactive boys almost grown up, I: psychiatric status. Arch Gen Psychiatry. 1985;42: 937–947.
3. Weiss G, Hechtman L, Milroy T, Perlman T. Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Adolesc Psychiatry. 1985;24: 211–220.
4. Bird HR, Canino G, Rubio-Stipec M, Gould MS, Ribera J, Sesman M, Woodbury M, Huertas-Goldman S, Pagan A, Sanchez-Lacay A, Moscoso M. Estimates of the prevalence of childhood maladjustment in a community survey in Puerto Rico: the use of combined measures. Arch Gen Psychiatry. 1988;45: 1120–1126.
5. Anderson JC, Williams S, McGee R, Silva PA. DSM-III disorders in preadolescent children: prevalence in a large sample from the general population. Arch Gen Psychiatry. 1987;44: 69–76.
6. Klein RG, Mannuzza S. The long-term outcome of the attention deficit disorder/hyperkinetic syndrome. In: Sagvolden T, Archer T, eds. Attention Deficit Disorder: Clinical and Basic Research. Hillside, NJ: Erlbaum Associates; 1989: 71–89.
7. Weiss G, Hechtman L, Perlman T, Hopkins J, Wener A. Hyperactives as young adults: a controlled prospective 10-year follow-up of 75 children. Arch Gen Psychiatry. 1979;36: 675–681.
8. Spencer T, Biederman J, Wilens T, Faraone S. Is attention deficit hyperactivity disorder in adults a valid disorder? Harvard Rev Psychiatry. 1994;1: 326–335.
9. Klein RG, Mannuzza S. Long-term outcome of hyperactive children: a review. J Am Acad Child Adolesc Psychiatry. 1991;30: 383–387.
10. Weiss G, Hechtman LT. Hyperactive Children Grown Up. New York, NY: The Guilford Press; 1986.
11. Thorley G. Review of follow-up and follow-back studies of childhood hyperactivity. Psychol Bull. 1984;96: 116–132.
12. Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey K, Mick E, Krifcher-Lehman B, Doyle A. Patterns of psychiatric comorbidity, cognition and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150: 1792–1798.
13. Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B, Moore C, Sprich Buckminster S, Ugaglia K, Jellinek MS, Steingard R, Spencer T, Norman D, Kolodny R, Kraus I, Perrin J, Keller MB, Tsuang MT. Further evidence for familygenetic risk factors in attention deficit hyperactivity disorder: patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples. Arch Gen Psychiatry. 1992;49: 728–738.
14. Biederman J, Faraone SV, Keenan K, Knee D, Tsuang MT. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiatry. 1990;29: 526–533.
15. Goodman R. Genetic factors in hyperactivity account for about half of the explainable variance. BMJ. 1989;298: 1407–1408.
16. Goodman R, Stevenson J. A twin study of hyperactivity, I: an examination of hyperactivity scores and categories derived from Rutter teacher and parent questionnaires. J Child Psychol Psychiatry. 1989;30: 671–689.
17. Goodman R, Stevenson J. A twin study of hyperactivity, II: the aetiological role of genes, family relationships and perinatal adversity. J Child Psychol Psychiatry. 1989;30: 691–709.
18. Faraone S, Biederman J, Chen WJ, Krifcher B, Keenan K, Moore C, Sprich-Buckminster S, Tsuang M. Segregation analysis of attention deficit hyperactivity disorder: evidence for single gene transmission. Psychiatry Genet. 1992;2: 257–275.
19. Faraone S, Biederman J. Is attention deficit hyperactivity disorder familial? Harvard Rev Psychiatry. 1994;1: 271–287.
20. Deutsch CK, Matthysse S, Swanson JM, Farkas LG. Genetic latent structure analysis of dysmorphology in attention deficit disorder. J Am Acad Child Adolesc Psychiatry. 1990;29: 189–194.
21. Manshadi M, Lippmann S, O'Daniel RG, Blackman A. Alcohol abuse and attention deficit disorder. J Clin Psychiatry. 1983;44: 379–380.
22. Zametkin AJ, Nordahl TE, Gross M, King C, Semple WE, Rumsey J, Hamburger S, Cohen RM. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med. 1990;323: 1361–1366.
23. Zametkin AJ, Liebenauer LL, Fitzgerald GA, King AC, Minkunas DV, Herscovitch P, Yamada EM, Cohen RM. Brain metabolism in teenagers with attentiondeficit hyperactivity disorder. Arch Gen Psychiatry. 1993;50: 333–340.
24. Wood DR, Reimherr FW, Wender PH, Johnson GE. Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report. Arch Gen Psychiatry. 1976;33: 1453–1460.
25. Wender PH, Reimherr FW, Wood D, Ward M. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry. 1985;142: 547–552.
26. Mattes JA, Boswell L, Oliver H. Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry. 1984;41: 1059–1063.
27. Gualtieri CT, Ondrusek MG, Finley C. Attention deficit disorders in adults. Clin Neuropharmacol. 1985;8: 343–356.
28. Wilens T, Biederman J. The stimulants. In: Schaffer D, ed. Psychiatric Clinics of North America. Philadelphia, Pa: WB Saunders Co; 1992: 191–222.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
30. Pliszka SR. Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry. 1989;28: 882–887.
31. Biederman J, Newcorn J, Sprich-Buckminster S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry. 1991;148: 564–577.
32. Biederman J, Newcorn J. Comorbidity in attention deficit hyperactivity disorder. In: Task Force on DSM-IV, ed. Source Book for DSM-IV. Washington, DC: American Psychiatric Association. In press.
33. Biederman J, Baldessarini RJ, Wright V, Keenan K, Faraone S. A double-blind placebo controlled study of desipramine in the treatment of attention deficit disorder, III: lack of impact of comorbidity and family history factors on clinical response. J Am Acad Child Adolesc Psychiatry. 1993;32: 199–204.
34. Spitzer RL, Williams JB, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R—Non-Patient Edition (SCID-NP, Version 1.0). Washington, DC: American Psychiatric Association; 1990.
35. Orvaschel H. Psychiatric interviews suitable for use in research with children and adolescents. Psychopharmacol Bull. 1985;21: 737–745.
36. Biederman J, Rosenbaum JF, Hirshfeld DR, Faraone SV, Bolduc EA, Gersten M, Meminger SR, Kagan J, Snidman N, Reznick JS. Psychiatric correlates of behavioral inhibition in young children of parents with and without psychiatric disorders. Arch Gen Psychiatry. 1990;47: 21–26.
37. Wechsler D. Manual for the Wechsler Adult Intelligence Scale—Revised. San Antonio, Tex: The Psychological Corp; 1981.
38. Jastak JF, Jastak S. The Wide Range Achievement Test—Revised. Wilmington, Del: Jastak Associates; 1985.
39. Faraone S, Biederman J. Genetics of attention-deficit hyperactivity disorder. Child Adolesc Psychiatr Clin North Am. 1994;3: 285–302.
40. Faraone SV, Santangelo S. Methods in genetic epidemiology. In: Fava M, Rosenbaum JF, eds. Research Designs and Methods in Psychiatry. New York, NY: Elsevier Science Publishing Co Ine; 1992: 93–118.
41. Holllngshead AB. Four Factor Index of Social Status. New Haven, Conn: Yale University Department of Sociology; 1975.
42. CGI (Clinical Global Impression) Scale—NIMH. Psychopharmacol Bull. 1985;21: 839–844.
43. Barkley RA. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment New York, NY: The Guilford Press; 1990.
44. Ekstrom D, Quade D, Golden RN. Statistical analysis of repeated measures in psychiatric research. Arch Gen Psychiatry. 1990;47: 770–772.
45. Lavori P. ANOVA, MANOVA, my black hen: comments on repeated measures. Arch Gen Psychiatry. 1990;47: 775–778.
46. Tukey JW. Exploratory Data Analysis. Reading, Mass: Addison-Wesley Publishing Co; 1977.
47. Rapport MD, Jones JT, DuPaul GJ, Kelly KL, Gardner MJ, Tucker SB, Shea MS. Attention deficit disorder and methylphenidate: group and single-subject analyses of dose effects on attention in clinic and classroom settings. J Clin Child Psychol. 1987;16: 329–338.
48. Barkley RA, DuPaul GJ, McMurray MB. Attention deficit disorder with and without hyperactivity: clinical response to three dose levels of methylphenidate. Pediatrics. 1991;87: 519–531.
49. Gualtieri CT, Hicks RE, Patrick K, Schroeder SR, Breese GR. Clinical correlates of methylphenidate blood levels. Ther Drug Monit. 1984;6: 379–392.
50. Patrick K, Mueller R, Gualtieri C, Breese GR. Pharmacokinetics and actions of methylphenidate. In: Meltzer H, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press; 1987: 1387–1395.
51. Faraone SV, Simpson JC, Brown WA. Mathematical models of complex doseresponse relationships: implications for experimental design in psychopharmacologic research. Stat Med. 1992;11: 685–702.
52. Faraone SV, Biederman J, Keenan K, Tsuang MT. A family-genetic study of girls with DSM-III attention deficit disorder. Am J Psychiatry. 1991;148: 112–117.
53. Wender PH, Reimherr FW, Wood DR. Attention deficit disorder (‘minimal brain dysfunction’) in adults: a replication study of diagnosis and drug treatment. Arch Gen Psychiatry. 1981;38: 449–456.
54. Safer DJ, Krager JM. A survey of medication treatment for hyperactive/inattentive students. JAMA. 1988;260: 2256–2258.
55. Shaywitz SE, Shaywitz BA. Attention deficit disorder: current perspectives. Pediatr Neurol. 1987;3: 129–135.
56. Biederman J, Faraone SV, Knee D, Munir K. Retrospective assessment of DSMIII attention deficit disorder in non-referred individuals. J Clin Psychiatry. 1990;51: 102–107.
57. Wender P, Wood DR, Reimherr FW. Pharmacological treatment of attention deficit disorder, residual type (ADDRT, ‘minimal brain dysfunction,’ ‘hyperactivity’) in adults. Psychopharmacol Bull. 1985;21: 222–232.